Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovex International (INVX) EBITDA (2016 - 2026)

Innovex International filings provide 17 years of EBITDA readings, the most recent being $14.3 million for Q4 2025.

  • On a quarterly basis, EBITDA fell 32.69% to $14.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $96.2 million, a 26.76% decrease, with the full-year FY2025 number at $96.2 million, down 25.6% from a year prior.
  • EBITDA hit $14.3 million in Q4 2025 for Innovex International, down from $40.5 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $85.0 million in Q3 2024 to a low of -$72.2 million in Q4 2021.
  • Median EBITDA over the past 5 years was $13.3 million (2022), compared with a mean of $10.8 million.
  • Biggest five-year swings in EBITDA: crashed 520.51% in 2021 and later surged 483.65% in 2024.
  • Innovex International's EBITDA stood at -$72.2 million in 2021, then soared by 201.0% to $72.9 million in 2022, then plummeted by 76.67% to $17.0 million in 2023, then rose by 24.6% to $21.2 million in 2024, then plummeted by 32.69% to $14.3 million in 2025.
  • The last three reported values for EBITDA were $14.3 million (Q4 2025), $40.5 million (Q3 2025), and $22.1 million (Q2 2025) per Business Quant data.